Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Option Care Health, Inc. (NASDAQ:OPCH) has earned a consensus recommendation of “Moderate Buy” from the twelve analysts that are covering the stock, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $35.6667.

A number of research analysts have recently weighed in on OPCH shares. Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Friday, October 31st. Morgan Stanley assumed coverage on shares of Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price target on the stock. Finally, TD Cowen cut their price objective on Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research report on Monday, November 3rd.

Option Care Health Stock Performance

NASDAQ OPCH opened at $28.28 on Friday. The business has a 50 day moving average price of $27.72 and a 200 day moving average price of $29.51. The company has a market capitalization of $4.49 billion, a P/E ratio of 22.62, a PEG ratio of 1.74 and a beta of 0.88. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of Option Care Health stock in a transaction dated Monday, November 3rd. The shares were acquired at an average cost of $25.98 per share, for a total transaction of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Norman L. Wright acquired 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The shares were bought at an average cost of $29.31 per share, for a total transaction of $99,976.41. Following the purchase, the director owned 15,501 shares of the company’s stock, valued at approximately $454,334.31. The trade was a 28.21% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 61,411 shares of company stock valued at $1,637,416 over the last three months. 0.64% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors have recently modified their holdings of the company. USA Financial Formulas acquired a new stake in Option Care Health during the second quarter worth approximately $26,000. Cornerstone Planning Group LLC raised its holdings in Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock valued at $30,000 after acquiring an additional 1,067 shares during the last quarter. Northwestern Mutual Wealth Management Co. lifted its stake in shares of Option Care Health by 1,492.9% during the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock worth $31,000 after purchasing an additional 836 shares during the period. Advisory Services Network LLC acquired a new stake in shares of Option Care Health during the third quarter worth $35,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Option Care Health in the second quarter valued at $37,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.